Efficacy and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
Public ClinicalTrials.gov record NCT00409682. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
All trial information on this site comes from the official ClinicalTrials.gov public API (clinicaltrials.gov/api/v2), run by the U.S. National Library of Medicine. We only display that public information; we do not add opinions, endorsements, or any other intent. Always review the official ClinicalTrials.gov record for the latest information.
Official title
A Multi-Center, Double-Blind Study to Evaluate the Safety, Efficacy and Pharmacokinetics of the Human Anti-TNF Monoclonal Antibody Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
The purpose of this study is to determine Efficacy, Pharmacokinetics, and Safety of Adalimumab in Pediatric Subjects With Moderate to Severe Crohn's Disease
Study identification
- NCT ID
- NCT00409682
- Recruitment status
- Completed
- Study type
- Interventional
- Phase
- Phase 3
- Enrollment
- 192 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 6 Years to 17 Years
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Apr 2007 (Type not available)
- Primary completion
- May 2010 (Actual)
- Completion
- May 2010 (Actual)
- Last update posted
- Aug 4, 2011
2007 – 2010
United States locations
- U.S. sites
- 26
- U.S. states
- 18
- U.S. cities
- 25
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Site Reference ID/Investigator# 10287 | Los Angeles | California | 90095-1752 | — |
| Site Reference ID/Investigator# 5223 | Orange | California | 92868 | — |
| Site Reference ID/Investigator# 4984 | San Francisco | California | 94143 | — |
| Site Reference ID/Investigator# 5222 | Aurora | Colorado | 80045 | — |
| Site Reference ID/Investigator# 5676 | Hartford | Connecticut | 06106 | — |
| Site Reference ID/Investigator# 4911 | Orlando | Florida | 32801 | — |
| Site Reference ID/Investigator# 7640 | Orlando | Florida | 32806 | — |
| Site Reference ID/Investigator# 5904 | Atlanta | Georgia | 30342 | — |
| Site Reference ID/Investigator# 4316 | Chicago | Illinois | 60637 | — |
| Site Reference ID/Investigator# 5901 | Maywood | Illinois | 60153 | — |
| Site Reference ID/Investigator# 4912 | Indianapolis | Indiana | 46202 | — |
| Site Reference ID/Investigator# 4317 | Baltimore | Maryland | 21287 | — |
| Site Reference ID/Investigator# 5102 | Rochester | Minnesota | 55905 | — |
| Site Reference ID/Investigator# 4285 | Saint Paul | Minnesota | 55114 | — |
| Site Reference ID/Investigator# 3826 | Las Vegas | Nevada | 89109 | — |
| Site Reference ID/Investigator# 6182 | Morristown | New Jersey | 07962 | — |
| Site Reference ID/Investigator# 8801 | Buffalo | New York | 14222 | — |
| Site Reference ID/Investigator# 3734 | Mineola | New York | 11501 | — |
| Site Reference ID/Investigator# 4913 | New Hyde Park | New York | 11040 | — |
| Site Reference ID/Investigator# 6257 | Chapel Hill | North Carolina | 27599 | — |
| Site Reference ID/Investigator# 4909 | Cincinnati | Ohio | 45229 | — |
| Site Reference ID/Investigator# 4914 | Columbus | Ohio | 43205 | — |
| Site Reference ID/Investigator# 5892 | Philadelphia | Pennsylvania | 19104 | — |
| Site Reference ID/Investigator# 6354 | Nashville | Tennessee | 37232 | — |
| Site Reference ID/Investigator# 4983 | Seattle | Washington | 98105 | — |
| Site Reference ID/Investigator# 4950 | Milwaukee | Wisconsin | 53226 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 19 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT00409682, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Aug 4, 2011 · Synced Nov 7, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete public registry record, listed eligibility criteria, and available contact information for NCT00409682 live on ClinicalTrials.gov.